| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |